PharmedOut is a project at Georgetown that advances evidence-based prescribing and educates about pharmaceutical and medical device marketing practices.
Georgetown University Med Ctr
Joined May 2011
- Tweets4.3K
- Following504
- Followers2.2K
- Likes420
Pinned Tweet
Fugh-Berman's latest op-ed: "The pharmaceutical industry and the associations that they fund keep trying to medicate perfectly normal men. Hegseth's pronouncement certainly benefits testosterone manufacturers... but it will hurt the health of soldiers."
durangoherald.com/articles/o…
"Researchers have outlined policies to lower healthcare costs and improve public health e.g limiting drug monopolies and improving access to healthy food. What’s not on the list? Skipping clinical trials to sell unproven treatments that could harm people."
kffhealthnews.org/public-hea…
A physician wanted to opt-out of sharing her health data with MyChart / EPIC, what followed was an impossible process that included "a notary, a hospital that won’t honor its own policies and employees that gave [her] wrong information."
themarkup.org/privacy/2026/1…
"Notably, the research found a clear relationship between meals and inappropriate prescriptions. The more meals a doctor received from a company, the more of the company’s drug they prescribed."
statnews.com/pharmalot/2026/…
The DOJ alleged that CVS' "unlawful actions stemmed from decisions that prioritized corporate profits over patient safety," when the pharmacy knowingly filled invalid opioid prescriptions.
fiercehealthcare.com/payers/…
Kanter study finds 38% of FDA advisory committees 2013-22 had a patient or consumer representative tied to a pharma-funded advocacy organization
academic.oup.com/healthaffai…
Generation Patient calls for an Open Payments type database for influencers who are paid by pharmaceutical companies or telehealth companies
generationpatient.org/blog/2…
New Cochrane review on pharma promotion and docs finds that receipt of gifts and payments is associated with decreased prescribing appropriateness, more prescriptions and increased prescribing costs cochranelibrary.com/web/coch…
Lexchin, Mintzes, Fabbri, and Grundy’s commentary on new Cochrane review on Pharma promotion: “The more company-sponsored meals that doctors ate and the more gifts or payments they received, the more their prescribing deteriorated”
theconversation.com/drug-com…
Lessons learned from the history of the opioid and tobacco settlements in "How to Spend Billions From Big Tech" via: governing.com/finance/how-to…
PharmedOut retweeted
Several of the largest news organisations in the Netherlands have been fined thousands of euros for what regulators said was the unlawful promotion of GLP-1 medications
bmj.com/content/394/bmj-2026…
"Once promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being seen *and marketed* as a way to look and feel better generally... Novo Nordisk, in particular, has leaned into the shift" via @statnews
statnews.com/2026/09/28/glp1…
Cops and the K-Hole: The Hennepin Healthcare Forced Ketamine Studies with Carl Elliott MD, PhD @FearLoathingBTX this coming Tuesday, September 29th at noon ET (Zoom). Don't miss it: georgetown.zoom.us/meeting/r…
How Big Tobacco flooded the FDA with public comments to kill a menthol cigarette ban: Tens of thousands of the comments to the FDA were generated by PR campaigns by the makers of Newport and Marlboro Menthol, the two largest menthol brands in the U.S.
statnews.com/2026/09/25/fake…
1/2: On Sept 29th at 12PM ET, join us for Dr. Carl Elliott's talk, "Cops and the K-Hole: The Hennepin Healthcare Forced Ketamine Studies." Dr. Elliott will talk about the ethical issues around the ketamine clinical trials that occurred in Minnesota and...
georgetown.zoom.us/meeting/r…
ALT "Cops and the K-Hole: The Hennepin Healthcare Forced Ketamine Studies," with Carl Elliott MD, PhD on September 29th on zoom.
2/2: discuss the broader "ethics of conducting research on chemical restraints." You can learn more about the Hennepin Healthcare Forced Ketamine Studies from Dr. Elliott's article with Lauren Wilson here: pmc.ncbi.nlm.nih.gov/article…
“There’s a lot of naivete not just in the US but everywhere about drug companies educating anyone about drugs... [education] should be done by people who don’t have a financial interest," Fugh-Berman told Moneywise.
GLP-1 companies pay US doctors big bucks — as much as $1 million — to promote weight-loss drugs. That has critics weighing in
#GLP1 #Pharma #Healthcare
moneywise.com/news/top-stori…
